3BBLACKBIO vs ZOTA: Stock Comparison

3B Blackbio DX Ltd vs Zota Health Care Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Zota Health Care Ltd is the larger company by market capitalisation. 3B Blackbio DX Ltd shows a higher ROE, a higher dividend yield and lower leverage, while Zota Health Care Ltd shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of 3B Blackbio DX Ltd and Zota Health Care Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, 3BBLACKBIO is more favourable on 8 of 13 scored metrics and ZOTA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ZOTA is the larger company
₹4,432 Cr vs ₹1,098 Cr
P/E Ratio
ZOTA has a lower P/E
-60.28x vs 19x
P/B Ratio
3BBLACKBIO has a lower P/B
3.43x vs 6.43x
EPS
3BBLACKBIO has higher earnings per share
₹68.3 vs ₹-21.4
Dividend Yield
3BBLACKBIO has a higher dividend yield
0.34% vs 0.08%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
67.8% vs 57.5%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
31.1% vs 13.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric3BBLACKBIOZOTA
SectorHealthcare
IndustryPharmaceuticals

Price

Metric3BBLACKBIOZOTA
Live Price₹1,298.8₹1,274.9
Day Change0.5%-0.64%
Volume10,69457,134
52-Week High₹1,441.5₹1,740
52-Week Low₹1,085₹1,026.2
Distance from 52W High-9.9%-26.73%

Valuation

Metric3BBLACKBIOZOTA
Market Cap₹1,098 Cr₹4,432 Cr
P/E Ratio19x-60.28x
P/B Ratio3.43x6.43x
EPS₹68.3₹-21.4
Book Value₹378₹200
Dividend Yield0.34%0.08%

Growth

Metric3BBLACKBIOZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth57.5%67.8%
Qtr Profit Growth13.8%31.1%

Profitability & Leverage

Metric3BBLACKBIOZOTA
ROE19.8%-15%
ROCE25.5%-8.47%
Net Margin42.23%-13.98%
Operating Margin40%3.44%
Debt to Equity0.01x0.39x

Shareholding

As of Mar 2026 • change vs previous quarter
Metric3BBLACKBIOZOTA
Promoter Holding38.46%49.38%
FII Holding2.57%7.92% 0.29 pp
DII Holding1.98% 0.1 pp6.75% 0.35 pp
Public Holding54.51% 0.23 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B Blackbio DX Ltd and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.